Reports for ACT BUPRENORPHINE/NALOXONE
Brand name
ACT BUPRENORPHINE/NALOXONE
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02453916 |
Ingredients
NALOXONE BUPRENORPHINE |
Ingredient Strength
2 MG 8 MG |
ATC Code
N07BCN07BC |
ATC Descriptor
DRUGS USED IN ADDICTIVE DISORDERS DRUGS USED IN ADDICTIVE DISORDERS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| ACT BUPRENORPHINE/NALOXONE | 30 | Resolved | 2019-09-26 | 2020-01-24 | 94896 |
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|